Potential Risk of Overlooking Biased Reporting of Vaccination against Novel Coronavirus Disease 2019: Lessons from Japan's Experience with the Human Papillomavirus Vaccine
Description
Vaccination is a crucial and evidence-based measure against novel coronavirus disease 2019 (COVID-19) implemented worldwide, including in Japan, where more than 67% of the population has received more than three doses of vaccination as of February
